Early career · publishing since 2019Rising activity
Lung Cancer Research StudiesGlioma Diagnosis and TreatmentLung Cancer Treatments and MutationsCancer therapeutics and mechanismsBrain Metastases and Treatment
Publications
43
Citations
784
Est. group size
~9
Recurring co-author estimate
Active years
7
Publishing since 2019
In context
Among 1,353 early career Medicine PIs within our index
Citations: 784p25 74 · p75 317 · cohort median 157
Publications / year (recent): 6.0p25 1.8 · p75 4.4 · cohort median 2.6
Typically publishes in teams of ~7 · 3% small-team papers (≤3 authors) · across 18 venues
Publication cadence
Publications per year over the last 10 years — averaging 6.0/year recently
Recent publications
- Leveraging translational insights toward precision medicine approaches for brain metastases
Nature Cancer · 2023
- The ERK inhibitor LY3214996 augments anti-PD-1 immunotherapy in preclinical mouse models of BRAFV600E melanoma brain metastasis
Neuro-Oncology · 2023
- Data from Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRAS<sup>G12C</sup>-Mutant Non–Small Cell Lung Cancer
2023
- Supplementary Figure from Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRAS<sup>G12C</sup>-Mutant Non–Small Cell Lung Cancer
2023
- Supplementary Figure from Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRAS<sup>G12C</sup>-Mutant Non–Small Cell Lung Cancer
2023
- Supplementary Data from Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRAS<sup>G12C</sup>-Mutant Non–Small Cell Lung Cancer
2023
- Supplementary Figure from Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRAS<sup>G12C</sup>-Mutant Non–Small Cell Lung Cancer
2023
- Supplementary Figure from Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRAS<sup>G12C</sup>-Mutant Non–Small Cell Lung Cancer
2023
- Supplementary Data from Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRAS<sup>G12C</sup>-Mutant Non–Small Cell Lung Cancer
2023
- Supplementary Figure from Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRAS<sup>G12C</sup>-Mutant Non–Small Cell Lung Cancer
2023
- Supplementary Figure from Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRAS<sup>G12C</sup>-Mutant Non–Small Cell Lung Cancer
2023
- Data from Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRAS<sup>G12C</sup>-Mutant Non–Small Cell Lung Cancer
2023
- Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non–Small Cell Lung Cancer
Clinical Cancer Research · 2022
- Emerging Systemic Treatment Perspectives on Brain Metastases: Moving Toward a Better Outlook for Patients
American Society of Clinical Oncology Educational Book · 2022
- A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses
Pediatric Neurology · 2022
Publishes in
- Neuro-Oncology×6
- Neurosurgery×2
- Neurocritical Care×2
- JAMA Network Open×1
- Clinical Cancer Research×1
Similar researchers
By research-topic overlap
- Allison Schepers
Medicine · University of Michigan
- Jing Su
Medicine · Indiana University
- Logan Roof
Medicine · The Ohio State University
- Misty Dawn Shields
Medicine · Indiana University
- D. Carbone
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile